M Cornberg

Summary

Affiliation: Hannover Medical School
Country: Germany

Publications

  1. Cornberg M, Schlevogt B, Rademacher J, Schwarz A, Sandherr M, Maschmeyer G. [Specific infections in organ transplantation]. Internist (Berl). 2016;57:38-48 pubmed publisher
    ..In this context Aspergillus spp. are one of the most commonly occurring fungal diseases. The epidemiology, risk factors, diagnostics, prophylaxis and therapy of invasive aspergillosis are presented. ..
  2. Cornberg M, Wedemeyer H. Hepatitis C virus infection from the perspective of heterologous immunity. Curr Opin Virol. 2016;16:41-48 pubmed publisher
    ..This review discusses how other infections can alter the natural course of hepatitis C and how HCV infection influence unrelated infections. ..
  3. Bartenschlager R, Cornberg M, Pietschmann T. [Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E]. Internist (Berl). 2017;58:666-674 pubmed publisher
    ..Treatment options are still limited and individualized management is based on tailoring immunosuppressive therapy and therapy with ribavirin. Thus, personalized therapy of hepatitis E virus infection is still limited. ..
  4. Höner zu Siederdissen C, Maasoumy B, Cornberg M. What is new on HBsAg and other diagnostic markers in HBV infection?. Best Pract Res Clin Gastroenterol. 2017;31:281-289 pubmed publisher
    ..Here we review the current evidence how to use these markers and discuss open issues that require additional research. ..

Detail Information

Publications4

  1. Cornberg M, Schlevogt B, Rademacher J, Schwarz A, Sandherr M, Maschmeyer G. [Specific infections in organ transplantation]. Internist (Berl). 2016;57:38-48 pubmed publisher
    ..In this context Aspergillus spp. are one of the most commonly occurring fungal diseases. The epidemiology, risk factors, diagnostics, prophylaxis and therapy of invasive aspergillosis are presented. ..
  2. Cornberg M, Wedemeyer H. Hepatitis C virus infection from the perspective of heterologous immunity. Curr Opin Virol. 2016;16:41-48 pubmed publisher
    ..This review discusses how other infections can alter the natural course of hepatitis C and how HCV infection influence unrelated infections. ..
  3. Bartenschlager R, Cornberg M, Pietschmann T. [Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E]. Internist (Berl). 2017;58:666-674 pubmed publisher
    ..Treatment options are still limited and individualized management is based on tailoring immunosuppressive therapy and therapy with ribavirin. Thus, personalized therapy of hepatitis E virus infection is still limited. ..
  4. Höner zu Siederdissen C, Maasoumy B, Cornberg M. What is new on HBsAg and other diagnostic markers in HBV infection?. Best Pract Res Clin Gastroenterol. 2017;31:281-289 pubmed publisher
    ..Here we review the current evidence how to use these markers and discuss open issues that require additional research. ..